Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners(2023)
摘要
Early and effective diagnosis of immune-related adverse events through the search for predictive biomarkers like drug factors and individual risk factors will allow targeted surveillance leading to a better tolerance.
更多查看译文
关键词
Hodgkin’s lymphoma,Nivolumab,cardiopathy,drug-induced pneumonitis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要